I have been benchmarking EML shares against various counters listed in the US and I think ex-shareholders have done a massive favour to institution holders by selling off early. Institution guys have accumulated a great deal whenever share price hits around this range. And it’s all perfect for them since they rotate from high risk, super inflated NASDAQ valuations to fundamentally strong (strong GM, Op cash flows, opportunistic strategic acquisitions), relatively low risk and significantly undersold stocks, in particular EML.
EML is nowhere near pre-pandemic levels, even though with the addition of PFS and Sentenial into the fray, and some CBI clarification. It thoroughly deserves re-rating with PFS. I can understand if Sentenial has yet to prove itself.
It’s very unfortunate but hope our existing shareholders see that the potential for EML is one that can truly propel in 2022. I remain very bullish on this one.
I have been benchmarking EML shares against various counters...
-
- There are more pages in this discussion • 499 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EML (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.0¢ |
Change
0.010(1.09%) |
Mkt cap ! $348.8M | |||
| Open | High | Low | Value | Volume |
| 92.5¢ | 94.0¢ | 90.8¢ | $885.4K | 954.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 385011 | 93.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 5047 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| EML (ASX) Chart |